Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

Orthovita prices 7.7M shares at $3.25/share; plans to buy Vitagel

Nov. 20, 2006

By Amanda Pedersen

Deals roundup: Reflect set to gorge on merger agreements as growth strategy

Nov. 17, 2006

By Amanda Pedersen

FDA approves Latitude system with EMR data integration

Nov. 16, 2006

By Amanda Pedersen

WorldHeart to cut workforce; gets $14 million from investors

Nov. 15, 2006

By Amanda Pedersen

FDA approves Latitude system with EMR data integration

Nov. 15, 2006

By Amanda Pedersen

Transcend, out of ForSight Labs, gathers in Series A $7 million

Nov. 10, 2006

By Amanda Pedersen

Tug-of-war heats up as cuts to doctors nears Jan. 1 deadline

Nov. 9, 2006

By Amanda Pedersen

Web-based tool a longer-range assay for breast cancer risk

Nov. 9, 2006

By Amanda Pedersen

Web-based tool a longer-range tool for breast cancer risk

Nov. 8, 2006

By Amanda Pedersen

Boston Scientific and EndoTex move closer to sealing merger

Nov. 7, 2006

By Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...